Name: A New Resorbable Magnesium Scaffold for de Novo Coronary Lesions (DREAMS 3G): One-Year Results of the BIOMAG-1 First-In-Human Study
Uploaded: 2023-09-01T10:57:05+01:00
Duration: 3 min 21 s
Description: In this interview, Prof Michael Haude (Rheinlandklinkum, DE) explains the DREAMS 3G device, what the BIOMAG-I study is and what impact this has on the data for the future of scaffolds.

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

A New Resorbable Magnesium Scaffold for de Novo Coronary Lesions (DREAMS 3G): One-Year Results of the BIOMAG-1 First-In-Human Study

Published: 01 Sep 2023

Views:
403
Likes:
0

Average (ratings)

No ratings

Your rating

In this interview, Prof Michael Haude (Rheinlandklinkum, DE) explains the DREAMS 3G device, what the BIOMAG-I study is and what impact this has on the data for the future of scaffolds.

This video is supported by

Comments

You must be to comment. If you are not registered, you can register here.